share_log

Eli Lilly and Co | DEFA14A: Others

Eli Lilly and Co | DEFA14A: Others

禮來 | DEFA14A:其他
SEC announcement ·  03/22 16:29
Moomoo AI 已提取核心訊息
Eli Lilly and Co has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement. This filing, known as a Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Eli Lilly and Co, the registrant, indicating that no third party was involved in the filing process. Furthermore, the company has confirmed that no filing fee was required for this submission. The definitive additional materials are part of the company's ongoing communication with its shareholders and the SEC.
Eli Lilly and Co has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement. This filing, known as a Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Eli Lilly and Co, the registrant, indicating that no third party was involved in the filing process. Furthermore, the company has confirmed that no filing fee was required for this submission. The definitive additional materials are part of the company's ongoing communication with its shareholders and the SEC.
作爲委託書的一部分,禮來公司已向美國證券交易委員會(SEC)提交了明確的補充材料。這份文件被稱爲附表14A,是1934年《證券交易法》第14(a)條的要求。這些材料是由註冊人禮來公司提交的,表明沒有第三方參與申報流程。此外,該公司已確認本次提交不需要任何申請費。最終的額外材料是公司與股東和美國證券交易委員會持續溝通的一部分。
作爲委託書的一部分,禮來公司已向美國證券交易委員會(SEC)提交了明確的補充材料。這份文件被稱爲附表14A,是1934年《證券交易法》第14(a)條的要求。這些材料是由註冊人禮來公司提交的,表明沒有第三方參與申報流程。此外,該公司已確認本次提交不需要任何申請費。最終的額外材料是公司與股東和美國證券交易委員會持續溝通的一部分。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息